InGen BioSciences' primary focus is on infectious diseases and immunology, including human leucocyte antigen (HLA) testing. The group's distribution arm, InGen, supplies a large selection of high-performance reagents combined with platform analysis. Its research and development (R&D) activities are designed to bring innovative tests to market that are minimally invasive, fast, cost-effective and clinically relevant.
UK NEQAS IMPROVES PATIENT CARE
We aim to improve patient care through monitoring the quality of tests and their reporting, in an independent manner and on a not-for-profit basis.
We are here to help ensure optimal quality in testing for the benefit of patients.
We believe that the result of tests should be:
The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026
Grand Hotel, Birmingham
10 - 11 February, 2026
10 Union Street, London, SE1 1SZ
2 March, 2026
Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026
ICC Belfast, Northern Ireland
13 - 16 April, 2026
